[Severe liver damage following administration of valproic acid (Depakine)].
作者信息
Coeckelberghs M, van Caillie-Bertrand M, Bultinck J, Clara R
出版信息
Ned Tijdschr Geneeskd. 1980 Aug 23;124(34):1428-31.
PMID:6774268
Abstract
摘要
相似文献
1
[Severe liver damage following administration of valproic acid (Depakine)].
Ned Tijdschr Geneeskd. 1980 Aug 23;124(34):1428-31.
2
[Pathogenetic basis of pharmaceutical hepatitis induced by depakine in children].
Eksp Klin Gastroenterol. 2009(8):30-5.
3
[Valproic acid-induced idiosyncratic liver injury in 4 cases].
Zhonghua Er Ke Za Zhi. 2012 Dec;50(12):890-4.
4
Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity.
Hepatology. 2010 Jun;51(6):2227-8; author reply 2228. doi: 10.1002/hep.23688.
5
[Valproic acid induced-idiosyncratic hepatotoxicity].
An Pediatr (Barc). 2008 Nov;69(5):492-3. doi: 10.1157/13128011.
6
Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003.
Epilepsia. 2006 Dec;47(12):2027-31. doi: 10.1111/j.1528-1167.2006.00846.x.
7
Hepatotoxicity and valproate therapy.
Intern Med J. 2006 Nov;36(11):752-4. doi: 10.1111/j.1445-5994.2006.01183.x.
8
[Liver damage caused by valproic acid].
Ned Tijdschr Geneeskd. 1982 Nov 13;126(46):2111-3.
9
Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
Pharmacology. 2004 Feb;70(2):57-8. doi: 10.1159/000074668.
10
[Depakene (sodium valproate) in the treatment of epilepsy in children and adolescents: efficiency and safety].
Zh Nevrol Psikhiatr Im S S Korsakova. 2001;101(6):20-7.
Zotero 插件